1. Home
  2. GVA vs ALKS Comparison

GVA vs ALKS Comparison

Compare GVA & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GVA
  • ALKS
  • Stock Information
  • Founded
  • GVA 1922
  • ALKS 1987
  • Country
  • GVA United States
  • ALKS Ireland
  • Employees
  • GVA N/A
  • ALKS N/A
  • Industry
  • GVA Military/Government/Technical
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GVA Industrials
  • ALKS Health Care
  • Exchange
  • GVA Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • GVA 4.8B
  • ALKS 4.9B
  • IPO Year
  • GVA 1990
  • ALKS 1991
  • Fundamental
  • Price
  • GVA $108.32
  • ALKS $30.99
  • Analyst Decision
  • GVA Strong Sell
  • ALKS Strong Buy
  • Analyst Count
  • GVA 1
  • ALKS 14
  • Target Price
  • GVA $76.00
  • ALKS $41.43
  • AVG Volume (30 Days)
  • GVA 802.3K
  • ALKS 2.0M
  • Earning Date
  • GVA 10-30-2025
  • ALKS 10-23-2025
  • Dividend Yield
  • GVA 0.48%
  • ALKS N/A
  • EPS Growth
  • GVA 70.18
  • ALKS 21.99
  • EPS
  • GVA 3.11
  • ALKS 2.08
  • Revenue
  • GVA $4,078,324,000.00
  • ALKS $1,505,296,000.00
  • Revenue This Year
  • GVA $12.76
  • ALKS N/A
  • Revenue Next Year
  • GVA $9.12
  • ALKS $1.59
  • P/E Ratio
  • GVA $34.71
  • ALKS $14.89
  • Revenue Growth
  • GVA 7.17
  • ALKS N/A
  • 52 Week Low
  • GVA $69.08
  • ALKS $25.17
  • 52 Week High
  • GVA $112.16
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • GVA 50.23
  • ALKS 64.24
  • Support Level
  • GVA $106.60
  • ALKS $26.99
  • Resistance Level
  • GVA $110.36
  • ALKS $31.68
  • Average True Range (ATR)
  • GVA 2.29
  • ALKS 0.83
  • MACD
  • GVA -0.32
  • ALKS 0.40
  • Stochastic Oscillator
  • GVA 32.78
  • ALKS 85.29

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: